Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMM910 in postmenopausal women with osteoporosis at very high fracture risk
CTR20263658Phase 2Active
- Sponsor
- Help Therapeutics
- Start
- Oct 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of HMM910 in postmenopausal osteoporosis, sponsored by Help Therapeutics. Started Oct 2026; status: active.
02
Drugs
HMM910
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on CTR20263658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263658.